Recent developments in the discovery of hepatitis C virus serine protease inhibitors – towards a new class of antiviral agents?

Author： Narjes Frank   Koch Uwe   Steinkühler Christian  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.2, 2003-02, pp. : 153-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 267-272

Informa Healthcare

Access to resources Recommend Favorite

Hepatitis C Virus Serine Protease Inhibitors: Current Progress and Future Challenges

By  

Current Medicinal Chemistry, Vol. 8, Iss. 8, 2001-07 ,pp. : 919-932

Bentham Science Publishers

Access to resources Recommend Favorite

New Developments in the Discovery of Agents to Treat Hepatitis C

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-04 ,pp. : 533-562

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Serine Protease Inhibitors as Anticoagulant Agents

By  

Current Pharmaceutical Design, Vol. 13, Iss. 3, 2007-01 ,pp. : 287-312

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 3-16

Bentham Science Publishers

Access to resources Recommend Favorite